Platelet integrin αIIbβ3 inhibitor rescues progression of apoptosis in human platelets

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 4261-4270

  Zhu, Jie ^a   Wang, Qinghang ^a   Nie, Yumei ^a   Yan, Rong ^b   Dai, Kesheng ^b   Zhou, Birong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Flow cytometry; Mitochondrial membranes; Phosphatidylserines; Platelet aggregation inhibitors

Indexed keywords

PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; THROMBIN; THROMBOCYTE ANTIGEN; TIROFIBAN; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; TYROSINE;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NORMAL HUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; THROMBOCYTE; THROMBOCYTE RICH PLASMA; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; FEMALE; MALE; METABOLISM;

ADULT; APOPTOSIS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REACTIVE OXYGEN SPECIES; THROMBIN; TYROSINE;

EID: 84995739794     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.900820     Document Type: Article

References (32)

1. King S, Short M, Harmon C: Glycoprotein IIb/IIIa Inhibitors: The resurgence of Tirofiban. Vascul Pharmacol, 2016; 78: 10–16
2. Leclerc JR: Platelet glycoprotein IIb/IIIa antagonists: Lessons learned from clinical trials and future directions. Crit Care Med, 2002; 30: 332–40
3. De Luca G, Savonitto S, van’t Hof AW et al: Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future. Drugs, 2015; 75: 1229–53
4. Tanaka KA, Katori N, Szlam F et al: Effects of tirofiban on haemostatic activation in vitro. Br J Anaesth, 2014; 93: 263–69
5. Estevez B, Shen B, Du X: Targeting integrin and integrin signaling in treating thrombosis. Arterioscler Thromb Vasc Biol, 2015; 35: 24–29
6. Leytin V, Mutlu A, Mykhaylov S et al: The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187. Haematologica, 2009; 94: 1783–84
7. Giordano A, Romano S, D’Angelillo A et al: Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis. Vascul Pharmacol, 2016; 80: 67–74
8. Leytin V: Apoptosis in the anucleate platelet. Blood Rev, 2012; 26: 51–63
9. Kile BT: The role of the intrinsic apoptosis pathway in platelet life and death. J Thromb Haemost, 2009; 7: 214–17
10. Leytin V, Allen DJ, Mutlu A: Mitochondrial control of platelet apoptosis: Effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest, 2009; 89: 374–84
11. Garcia-Souza LF, Oliveira MF: Mitochondria: Biological roles in platelet physiology and pathology. Int J Biochem Cell Biol, 2014; 50: 156–60
12. Gyulkhandanyan AV, Mutlu A, Freedman J: Markers of platelet apoptosis: Methodology and applications. J Thromb Thrombolysis, 2012; 334: 397–411
13. Brenner D, Mak TW: Mitochondrial cell death effectors. Curr Opin Cell Biol, 2009; 21: 871–77
14. White MJ, Kile BT: Apoptotic processes in megakaryocytes and platelets. Semin Hematol, 2010; 47: 227–34
15. Gyulkhandanyan AV, Mutlu A, Freedman J et al: Mitochondrial permeability transition pore (MPTP)-dependent and -independent pathways of mitochondrial membrane depolarization, cell shrinkage and microparticle formation during platelet apoptosis. Br J Haematol, 2015; 169: 142–45
16. Wang Z, Wang J, Xie R et al: Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. Int J Mol Sci, 2015; 16: 11087–100
17. Bakdash N, Williams MS: Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med, 2008; 45: 158–66
18. Lopez JJ, Salido GM, Gómez-Arteta E et al: Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost, 2007; 5: 1283–91
19. Guan W, Wang Z, Liu Y et al: Protective effects of tirofiban on ischemia/re-perfusion-induced renal injury in vivo and in vitro. Eur J Pharmacol, 2015; 761: 144–52
20. Leytin V, Allen DJ, Mykhaylov S et al: Thrombin-triggered platelet apoptosis. J Thromb Haemost, 2006; 4: 2656–63
21. Watson SP, Auger JM, McCarty OJ et al: GPVI and integrin aIIbb3 signaling in platelets. J Thromb Haemost, 2005; 3: 1752–62
22. Arnoult D: Mitochondrial fragmentation in apoptosis. Trends Cell Biol, 2007; 17: 6–12
23. Leytin V, Mykhaylov S, Starkey AF et al: Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia. Br J Haematol, 2006; 133: 78–82
24. Bertino AM, Qi XQ, Li J et al: Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion, 2003; 43: 857–66
25. Villarroel JP, Figueredo R, Guan Y et al: Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. J Surg Res, 2013; 184: 422–29
26. Skripchenko A, Myrup A, Thompson-Montgomery D et al: Periods without agitation diminish platelet mitochondrial function during storage. Transfusion, 2010; 50: 390–99
27. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci, 2005; 62: 971–88
28. Schoenwaelder SM, Yuan Y, Josefsson EC et al: Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood, 2009; 114: 663–66
29. Leung R, Gwozdz AM, Wang H et al: Persistence of procoagulant surface expression on activated human platelets: Involvement of apoptosis and aminophospholipid translocase activity. J Thromb Haemost, 2007; 5: 560–70
30. Lopez JJ, Salido GM, Gómez-Arteta E et al.:Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost, 2007; 5: 1283–91
31. Hagemeyer CE, Peter K: Targeting the platelet integrin GPIIb/IIIa. Curr Pharm Des, 2010; 16: 4119–33
32. Rukoyatkina N, Begonja AJ, Geiger J et al: Phosphatidylserine surface expression and integrin aIIbb3 activity on thrombin/convulxin stimulated platelets/particles of different sizes. Br J Haematol, 2009; 144: 591–602